Disruption of the PTEN/Akt/Foxo3a pathway through inhibition of PTEN results in Treg instability and the transitioning of suppressive Foxp3+ Tregs to proinflammatory ex-Tregs, leading to a more immunogenic microenvironment and substantial tumor regression (49–51). Here, AKT1 is linked to neoplasm.